ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,048.42
-0.46%
US Tech 100
16,957.20
-0.60%
Dow Jones
38,085.80
-0.98%
Brent Oil
88.105
1.01%
Bitcoin
64,826.74
0.85%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NuCana PLC (NCNA) Quote

NuCana PLC

NuCana PLC (NCNA)

NASDAQ
3.825
-0.015
( -0.39% )
Updated: 15:48:00
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
3.825
Bid
3.78
Ask
3.87
Volume
13,961
3.5405 Day's Range 4.00
0.00 52 Week Range 0.00
Market Cap
201.669M
Previous Close
3.84
Open
4.00
Last Trade
5
@
3.78
Last Trade Time
15:50:04
Financial Volume
$ 53,661
VWAP
3.8436
Average Volume (3m)
-
Shares Outstanding
52,793,000
Dividend Yield
-
PE Ratio
-7.30
Earnings Per Share (EPS)
-0.52
Revenue
-
Net Profit
-27.63M

About NuCana PLC

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of ... NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.nucana.com
Headquarters
London, Gbr
Founded
1970
NuCana PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NCNA. The last closing price for NuCana was $3.84. Over the last year, NuCana shares have traded in a share price range of $ 0.00 to $ 0.00.

NuCana currently has 52,793,000 shares outstanding. The market capitalization of NuCana is $201.67 million. NuCana has a price to earnings ratio (PE ratio) of -7.30.

NCNA Latest News

More News

NuCana Announces Completion of ADS Ratio Change

EDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the Company’s previously disclosed plans to change the ratio of its American Depositary...

April 16 2024
GlobeNewswire Inc.

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive and Promote Cancer Cell Death NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer...

April 09 2024
GlobeNewswire Inc.

NuCana Announces Plan to Implement ADS Ratio Change

EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from...

March 27 2024
GlobeNewswire Inc.

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024...

March 20 2024
GlobeNewswire Inc.

NuCana to Present at TD Cowen’s 44th Annual Health Care Conference

EDINBURGH, United Kingdom, Feb. 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...

February 27 2024
GlobeNewswire Inc.

NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

EDINBURGH, United Kingdom, Feb. 06, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will...

February 06 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

November 16 2023
Edgar (US Regulatory)

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Data Pipeline Continues to Advance with Data Updates Expected for all Programs in 2024 Well...

November 16 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

NCNA Discussion

View Posts
chemist72 chemist72 4 weeks ago
NCNA announces 1:25 reverse split.

https://finance.yahoo.com/news/nucana-announces-plan-implement-ads-203000210.html
👍️0
chemist72 chemist72 1 month ago
NCNA has until 5/6/2024 to attain NASDAQ's minimum bid requirement of $1.00.

So though not inevitable, I'd agree that the possibility of an RS is highly likely.

Another possibility is for NCNA to partner with a large pharma company to begin one or more clinical trials with one or more of their patented drugs. If they haven't had any conversations about this up to now, I'd say it's highly unlikely any partnership agreement could be finalized in the ~1 month remaining before they will be subject to delisting by NASDAQ.

Needless to say, I'm very glad I was able to sell all my NCNA shares during the recent runup. And I likely won't be buying any shares up to May 6. If NCNA does decide to do a reverse split to remain quoted on NASDAQ, I will reconsider my stance.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
I think a reverse split is inevitable
👍️0
chemist72 chemist72 1 month ago
Still on radar but not buying any yet.

Looking for something closer to $.30 or perhaps slightly lower ($.28-.29)

Not in a rush to buy back. Still a chance they get delisted or perhaps execute a reverse split to raise their bid price above $1. A lot of uncertainty in this ticker as far as I'm concerned. Was happy to sell my shares around $.80. Didn't have that many shares but was a nice profit anyway.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Wow. We might see .20’s
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Gap looking filled :) I just wonder who’s buying.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Good trade.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
In the .40’s. Looks like a good place to grab a little more. Can’t imagine it going into .30’s
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Whelp, GLAD I dumped this daily Cancer-Patent-Of-The-Hour routine long ago today!!! (See below where MY shares went, hours ago!!!)

👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Great DD, too!!! Boy, I got SUCKERED!! (But, I'll only cry just a few more hours --- see me, live, below!!)


"Yeah, sure!!! And I myself just got a Patent to kill CANCER too!!! I grow the Cancer cells in a Petri Dish, then toss ARCO-PREMIUM-TOP-TIER-GASOLINE on it, and hit it with my Bic CIGARETTE LIGHTER!!! Works every time!!!"
👍️0
chemist72 chemist72 1 month ago
Just did a patent search for NCNA and found ~17 patents they have received using PHOSPHORAMIDATE derivatives.

One dates back to 2016! -lol

https://patents.justia.com/assignee/nucana-plc
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: CONGRATS, Dude!!! You worked it as a PRO would!!! (I worked it like a FOOL!!! Dumped all awhile back, at a LOSS!! Good thing I did NOT 'toss-the-farm' at it!!) And indeed, just like you too emphasized, any OTHER firm would have HYPED-the-fluck out of any kind of Cancer-related Patent, but this firm did NOTHING.)

CONGRATS again!!!
👍️0
chemist72 chemist72 1 month ago
Was "lucky" and got up early this morning.

I was able to sell all my shares pre-market at around $.81 >

You're right to worry about the "stealth" patent though. Most companies would brag about even having an application in process in the US.

Wonder why they have been so secretive about this patent?
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Most worrisome here --- via my own stupid, belated hindsight --- was that there was NO Company PR, nor otherwise "NEWS", about their own new PATENT. THAT is really, really, really, WORRISOME!!!!
👍️0
chemist72 chemist72 1 month ago
Getting and staying over $1 is a big deal now.

If NCNA can do that they will not be in danger of delisting from NASDAQ. Otherwise delisting or a reverse split might be on the table. They have until May 6, 2024 to meet NASDAQ minimum bid price listing requirement.

https://ir.nucana.com/news-releases/news-release-details/nucana-announces-listing-transfer-nasdaq-capital-market
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Same. I have a starter. Will avg down if it hits where I want.
👍️0
chemist72 chemist72 1 month ago
Like I said, NCNA future all depends on what they can do with the patent.

If they are smart they already had "somethings" lined up before the approval. Now that approval has been achieved may take some time to finalize a deal with someone in big pharma. May go back into the 40's if the wait becomes more than a week or 2. But that is just my own guess.

Keeping on my radar for now.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Yeah. It may not happen. It has traded the float above the .50 area. Hit $1 in PM, so maybe it comes again
👍️0
chemist72 chemist72 1 month ago
Low so far today is $.571 >

$.40's seems a stretch at least for today. But if it gets that low will rebuy shares.

Future for this ticker depends on what they do with their brand new US Patent. Sell it outright or use it as "bait" for a partnership with big Pharma? (imo)
👍️0
Stock_Gambit Stock_Gambit 1 month ago
I wouldn’t mind seeing it in the .40’s before running though.
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: This may run now, since the FLUFF "news" baloney is OVER at the scam PR of the day, namely, @GXAI.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Let’s see if .40 gap closes.
👍️0
Stock_Gambit Stock_Gambit 1 month ago
Let’s see if they can get over $1 and hold
👍️0
chemist72 chemist72 1 month ago
They got the US Patent. Now what?
👍️0
TimeFades TimeFades 1 month ago
Strong patent news but over extended seems like, slow day in the market tho and holding so let’s see
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: I think this puppy is on the TOP of this list for SOME reason ---
https://www.benzinga.com/premarket
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: News about Patent for Cancer treatment.
https://beststocks.com/title-nucana-receives-us-patent-for-phosphora/
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: I inadvertently stumbled-up their PATENT news on BENZINGA. (But I guess that EVERYBODY already knew that; heck, see selfie video of ME below, just last week --- at least I'm humble.)

👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Here's today's (reclusive) NCNA Firm's Patent news item:
https://www.benzinga.com/wiim/24/03/37635513/nucana-shares-are-trading-higher-after-the-company-was-granted-u-s-patent-11925658-for-phosphoramida

"NuCana shares are trading higher after the company was granted U.S. Patent #11925658 for Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance"
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Unfortunately for ME, that's 1:00 a.m.!!! (I HATE San Diego!! By the Open, I get sloppy 3rd's, 4th's, or 5th's. I need WeBull, plus a stay-awake or 'Dracula-Drug'.)
👍️0
Awl416 Awl416 1 month ago
Wonder where this opens come 4am
👍️0
Invest-in-America Invest-in-America 1 month ago
NCNA: Cancer + England + Lots of Trials --- well, just may be a monster WINNING formula for Wednesday.
👍️0
Monksdream Monksdream 1 month ago
NCNA chart
👍️0
Awl416 Awl416 1 month ago
So…..
👍️0
Monksdream Monksdream 6 months ago
NCNA new 52 week low
👍️0
chemist72 chemist72 6 months ago
Move yesterday was probably due to anticipated presentations at a Cancer Therapeutics 2023 conference.

https://finance.yahoo.com/news/nucana-announces-presentations-aacr-nci-120000333.html
👍️0
jchords jchords 6 months ago
Moving on low volume
👍️0
Monksdream Monksdream 7 months ago
NCNA new 52 week low
👍️0
Monksdream Monksdream 7 months ago
NCNA new 52 week low
👍️0
bandit007 bandit007 2 years ago
I think we see $4 soon enough. By the end of this week or next. IMO. $NCNA
👍️0
bandit007 bandit007 2 years ago
Agreed. GL

$NCNA
👍️0
Sociocobb Sociocobb 2 years ago
This one is a no brainer.
👍️0
bandit007 bandit007 2 years ago
Loaded heavy end of day. Looking forward to tomorrow here. $NCNA
👍️0
Sociocobb Sociocobb 2 years ago
Undervalued even after the massive gains this month. Do not underestimate the recent patent infringement ruling out of Germany. More to come. Stand by...
👍️0
willlbone willlbone 2 years ago
Going under a dollar.
👍️0
STEVEN52 STEVEN52 3 years ago
Just my conjecture but the recent news gave it momentum, for sure!
👍️0
Marvy Marvy 3 years ago
Nah....that's not the reason...just look up the company...you'll see why. Its recent news
👍️0
STEVEN52 STEVEN52 3 years ago
Increasing volume and upward trend over the past 3 to 4 days could be indicative that the market may be sensing more FDA news or announcement in the short term. A good stock to hold IMHO.
👍️0
Marvy Marvy 3 years ago
Could be a big pharma one day
👍️0
crudeoil24 crudeoil24 3 years ago
NuCana Receives FDA Fast Track Designation For Acelarin (NUC-1031) For Treatment Of Biliary Tract Cancer.
👍️0

Your Recent History

NASDAQ
NCNA
NuCana
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved